Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ
Company Description
Progenics Pharmaceuticals, Inc. engages in developing medicines for oncology. It offers clinical trials of product candidates for prostate cancer, and resumed a pivotal trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. The company was founded by Paul J. Maddon on December 1,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States